Our Leaders:
Meet the team that’s revolutionizing disease interception.
-
Jeremy Stueven, MD, MBA
CHIEF EXECUTIVE OFFICER
⊙ Board Certified in Emergency Medicine
⊙ 15 years of real-life clinical experience
⊙ Patient-centric, results-driven entrepreneur
⊙ Transformative healthcare leader
-
Alan Nolley, Jr. JD
CHIEF ADMINISTRATIVE OFFICER
⊙ Business Law
⊙ Contracts
⊙ Human Resources
-
Darwin Harrison, MAcc
CHIEF FINANCIAL OFFICER/CHIEF OPERATING OFFICER
⊙ 30 years experience in healthcare finance
⊙ 30 years experience in execution of healthcare organizations
⊙ Extensive start-up experience
⊙ Expert in accounting & finance
-
Nate Wyatt
CHIEF SECURITY OFFICER
⊙ DevOps Expert
⊙ Software engineer
⊙ Formerly with NetSkope & Microsoft
⊙ Extensive Software Development
-
Jeff Wigdahl, PhD
CHIEF TECHNOLOGY OFFICER
⊙ PhD from the University of Padua
⊙ Strong background in image processing, machine learning, and vision-related research
⊙ Developed retinal vascular measurement software
⊙ NIH SBIR award winner
-
Davin Isakson
CHIEF SALES OFFICER
⊙ MBA from the University of Notre Dame
⊙ 20 years of experience driving revenue growth and client success
⊙ 20 years in the medical device and healthcare technology sectors
-
Michael Raciti, MD
CHIEF MEDICAL OFFICER
⊙ Board Certified Ophthalmologist
⊙ Telehealth retinal experience
⊙ Expert in diabetic retinopathy detection & treatment
Our Advisors
-
John Pitcher, MD
TRIAL/RETINAL ADVISOR
-
Vlad Matei, MD
RETINAL/MEDICAL ADVISOR
-
Darlene Harbour, BSN
CLINICAL RESEARCH
-
Kevin Walls
FDA EXPERT ADVISOR
-
Waneta Tuttle, PhD
TRAMWAY VENTURE PARTNERS
-
KickStart Fund
INVESTMENT ADVISOR
-
Brad Vale
TREO VENTURE PARTNERS
-
Lerner Venture Law
LEGAL ADVISOR
-
Sheppard & Mullin
HEALTHCARE/TELEHEALTH LAW
How Vitazi.ai can help
Technology has the potential to improve access to eye screening, reducing the progression of the disease for many and improving lives. If a screening could be done in minutes as part of a regular checkup, access to vital screening is solved. Going further, this could enable establishment of entirely new, systemic screening programs for several diseases within the space of Oculomics.
